Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2021 Feb 17;11(2):248.
doi: 10.3390/brainsci11020248.

HIV Infection and Related Mental Disorders

Affiliations
Review

HIV Infection and Related Mental Disorders

Marina Nosik et al. Brain Sci. .

Abstract

Over the more than thirty-year period of the human immunodeficiency virus type 1 (HIV-1) epidemic, many data have been accumulated indicating that HIV infection predisposes one to the development of mental pathologies. It has been proven that cognitive disorders in HIV-positive individuals are the result of the direct exposure of the virus to central nervous system (CNS) cells. The use of antiretroviral therapy has significantly reduced the number of cases of mental disorders among people infected with HIV. However, the incidence of moderate to mild cognitive impairment at all stages of HIV infection is still quite high. This review describes the most common forms of mental pathology that occur in people living with HIV and presents the current concepts on the possible pathogenetic mechanisms of the influence of human immunodeficiency virus (HIV-1) and its viral proteins on the cells of the CNS and the CNS's functions. This review also provides the current state of knowledge on the impact of the antiretroviral therapy on the development of mental pathologies in people living with HIV, as well as current knowledge on the interactions between antiretroviral and psychotropic drugs that occur under their simultaneous administration.

Keywords: ART; CNS; CNS cells; HIV-1; drug–drug interactions; neurocognitive disorders (HAND); psychotropic drugs.

PubMed Disclaimer

Conflict of interest statement

The authors declare no conflict of interest.

References

    1. WHO HIV/AIDS. [(accessed on 30 November 2020)]; Available online: https://www.who.int/news-room/fact-sheets/detail/hiv-aids.
    1. Legarth R.A., Ahlström M.G., Kronborg G., Larsen C.S., Pedersen C., Pedersen G., Mohey R., Gerstoft J., Obel N. Long-term mortality in HIV-infected individuals 50 years or older: A nationwide, population-based cohort study. J. Acquir. Immune Defic. Syndr. 2016;71:213–218. doi: 10.1097/QAI.0000000000000825. - DOI - PubMed
    1. Nakagawa F., May M., Phillips A. Life expectancy living with HIV: Recent estimates and future implications. Curr. Opin. Infect. Dis. 2013;6:17–25. doi: 10.1097/QCO.0b013e32835ba6b1. - DOI - PubMed
    1. Cutrell J., Jodlowski T., Bedimo R. The management of treatment-experienced HIV patients (including virologic failure and switches) Ther. Adv. Infect. Dis. 2020;7:2049936120901395. doi: 10.1177/2049936120901395. - DOI - PMC - PubMed
    1. Spudich S., Gonzalez-Scarano F. HIV-1-related central nervous system disease: Current issues in pathogenesis, diagnosis, and treatment. Cold Spring Harb. Perspect. Med. 2012;2:a007120. doi: 10.1101/cshperspect.a007120. - DOI - PMC - PubMed

LinkOut - more resources